Lenshil 4mg Capsule Overview
Lenshil 4mg Capsule contains the active ingredient Lenvatinib and is used to treat progressive or advanced thyroid cancer and previously untreated liver cancer in patients ineligible for surgical treatment. It works by inhibiting the growth of blood vessels in tumor cells. Anaplastic Thyroid Carcinoma and Hepatocellular Carcinoma are the common conditions treated.
Strength |
4 mg |
Packaging Size |
1×10 Capsules |
Brand |
Lenshil |
Composition |
Lenvatinib |
Manufacturer |
Shilpa Medicare |
Treatment |
Cancer |
Prescription/Non prescription |
Prescription |
Form |
Tablet |
Packaging Type |
Box |
Uses of Lenshil 4mg Capsule:
- Advanced thyroid cancer
- Liver cancer
- Certain types of kidney cancer
- Endometrial cancer
Therapeutic Effects: Lenshil 4mg Capsule blocks enzyme receptors, slowing the growth of cancer cells.
Interaction with other drugs: Inform your healthcare provider about all medications to avoid potential side effects.
Storage: Store Lenshil 4mg Capsule between 20°C to 25°C, protected from light.
Administration: Take Lenshil 4mg Capsule orally once daily, swallowed whole with water.
Safety Precautions:
- Unsafe during pregnancy and breastfeeding.
- May cause lung and liver side effects.
- Avoid alcohol consumption.
- Caution while driving or operating machinery.
Side Effects: Common side effects include changes in blood pressure, nausea, vomiting, and fatigue.
Advice: Maintain close communication with your healthcare provider, avoid pregnancy, use sunscreen, and maintain a healthy lifestyle.
Contact Seller +91 7875500999